Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 166
Filtrer
1.
Sci Rep ; 14(1): 14693, 2024 06 26.
Article de Anglais | MEDLINE | ID: mdl-38926545

RÉSUMÉ

Our research aimed to elucidate the mechanism by which aurintricarboxylic acid (ATA) inhibits plasma membrane Ca2+-ATPase (PMCA), a crucial enzyme responsible for calcium transport. Given the pivotal role of PMCA in cellular calcium homeostasis, understanding how it is inhibited by ATA holds significant implications for potentially regulating physiopathological cellular processes in which this pump is involved. Our experimental findings revealed that ATA employs multiple modes of action to inhibit PMCA activity, which are influenced by ATP but also by the presence of calcium and magnesium ions. Specifically, magnesium appears to enhance this inhibitory effect. Our experimental and in-silico results suggest that, unlike those reported in other proteins, ATA complexed with magnesium (ATA·Mg) is the molecule that inhibits PMCA. In summary, our study presents a novel perspective and establishes a solid foundation for future research efforts aimed at the development of new pharmacological molecules both for PMCA and other proteins.


Sujet(s)
Acide aurintricarboxylique , Calcium , Magnésium , Plasma Membrane Calcium-Transporting ATPases , Magnésium/métabolisme , Magnésium/pharmacologie , Acide aurintricarboxylique/pharmacologie , Plasma Membrane Calcium-Transporting ATPases/métabolisme , Plasma Membrane Calcium-Transporting ATPases/antagonistes et inhibiteurs , Calcium/métabolisme , Adénosine triphosphate/métabolisme , Membrane cellulaire/métabolisme , Membrane cellulaire/effets des médicaments et des substances chimiques , Animaux , Humains
2.
Toxicol Res (Camb) ; 13(2): tfae029, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38496382

RÉSUMÉ

Introduction: Aluminum Phosphide (AlP) poisoning constituted the most common cause of poisoning death in some low- and middle-income countries (LMICs). This study aimed to evaluate the safety and efficacy of oil-based gastric lavage (GL) compared with standard therapy for the treatment of AlP poisoning. Materials and methods. This systematic review complied with "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" (PRISMA) Protocols. A comprehensive search was carried out, identifying randomized controlled trials (RCTs), including anyone presenting within 6 h of exposure to AlP, and the administration of GL with oils, including liquid paraffin or coconut oil. Results: We identified 7 RCTs. The evidence from 4 RCTs indicates that GL with paraffin oil is an effective treatment for acute AlP poisoning, decreasing the mortality rate (RR = 0.62; 95% CI = 0.48 to 0.81; participants = 226; I 2 = 10%; low-quality evidence). We estimate the Number Needed to Treat of 4. Likewise, this intervention reduces the need for intubation and mechanical ventilation (RR = 0.62; 95% CI = 0.40 to 0.79; I2 = 0%; low-quality evidence). Regarding GL with coconut oil, the evidence from 4 RCTs, indicates a slight reduction in mortality (RR = 0.82; 95% CI = 0.69 to 0.98; participants = 112; I2 = 0%; very low-quality evidence). Conclusions: Limited evidence suggests that GL with paraffin oil is effective in reducing the mortality rate. Likewise, limited evidence showed in favor of paraffin oil concerning the need for intubation and mechanical ventilation. Very limited evidence suggests that GL with coconut oil could reduce mortality. Both interventions would have a benign safety profile.

3.
Viruses ; 15(9)2023 08 31.
Article de Anglais | MEDLINE | ID: mdl-37766255

RÉSUMÉ

Lower respiratory tract infections (LRIs) are a significant cause of disability-adjusted life-years (DALYs) across all age groups, especially in children under 9 years of age, and adults over 75. The main causative agents are viruses, such as influenza and respiratory syncytial virus (RSV). Viral LRIs in adults have historically received less attention. This study investigated the incidence of RSV and influenza in adult patients admitted to a referral hospital, as well as the clinical profile of these infections. Molecular testing was conducted on nasopharyngeal samples taken from a respiratory surveillance cohort comprising adult (15-59 years) and elderly (60+ years) hospitalized patients who tested negative for SARS-CoV-2, to determine the prevalence for influenza and RSV. Influenza was found to be less frequent among the elderly. The main symptoms of RSV infections were cough, fever, dyspnea, malaise, and respiratory distress, while headache, nasal congestion, a sore throat, and myalgia were most frequent in influenza. Elderly patients with RSV were not found to have more severe illness than adults under age 60, underscoring the importance of providing the same care to adults with this viral infection.


Sujet(s)
COVID-19 , Grippe humaine , Infections à virus respiratoire syncytial , Virus respiratoire syncytial humain , Enfant , Sujet âgé , Adulte , Humains , Adulte d'âge moyen , Infections à virus respiratoire syncytial/épidémiologie , Maladies négligées , Grippe humaine/épidémiologie , SARS-CoV-2
4.
Res Microbiol ; 174(7): 104083, 2023.
Article de Anglais | MEDLINE | ID: mdl-37257734

RÉSUMÉ

Persister cells and biofilms are associated with chronic urinary infections which are more critical when generated by multi-drug resistant bacteria. In this context, joint administration of phages and antibiotics has been proposed as an alternative approach, since it may decrease the probability to generate resistant mutants to both agents. In this work, we exposed cultures of uropathogenic Escherichia coli conjunctly to antibiotics and phages. We determined that MLP2 combined with antibiotics eradicates persister cells. Similarly, MLP1 and MLP3 impact viability of biofilm-forming cells when administered with ampicillin. Our findings suggest a feasible prophylactic and therapeutic use of these non-transducing phages.

5.
J Basic Microbiol ; 63(8): 877-887, 2023 Aug.
Article de Anglais | MEDLINE | ID: mdl-37154196

RÉSUMÉ

Beneficial Bacillus strains can be administered to livestock as probiotics to improve animal health. Cyclic lipopeptides produced by Bacillus such as surfactins may be responsible for some of the beneficial effects due to their anti-inflammatory and immunomodulatory activity. The aim of the present study was to isolate and evaluate the biocompatibility of native Bacillus spp. strains and their surfactin-like lipopeptides in vitro and in vivo to determine their potential to be used on animals. Biocompatibility of endospore suspensions (108 UFC/mL), and different dilutions (1:10; 1:50; 1:100; 1:500, and 1:1000) of Bacillus lipopeptide extracts containing surfactin was tested on Caco-2 cells by microculture tetrazolium-based colorimetric assay. Genotoxicity was tested on BALB/c mice (n = 6) administered 0.2 mL of endospore suspensions by the bone marrow erythrocyte micronuclei assay. All the isolates tested produced between 26.96 and 239.97 µg mL- 1 of surfactin. The lipopeptide extract (LPE) from isolate MFF1.11 demonstrated significant cytotoxicity in vitro. In contrast, LPE from MFF 2.2; MFF 2.7, TL1.11, TL 2.5, and TC12 had no cytotoxic effect (V% > 70%) on Caco-2 cells, not affecting cell viability signifficantly in most treatments. Similarly, none of the endospore suspensions affected cell viability (V% > 80%). Likewise, endospores did not cause genotoxicity on BALB/c mice. This study was elementary as a first step for a new line of research, since it allowed us to choose the safest isolates to keep working on the search of new potentially probiotic strains destined to production animals to improve their performance and health.


Sujet(s)
Bacillus , Animaux , Souris , Humains , Bacillus/métabolisme , Lipopeptides/pharmacologie , Lipopeptides/métabolisme , Cellules Caco-2 , Suspensions , Peptides cycliques/toxicité , Extraits de plantes , Bacillus subtilis/métabolisme
6.
Interface (Botucatu, Online) ; 27: e220537, 2023. ilus
Article de Espagnol | LILACS-Express | LILACS | ID: biblio-1440367

RÉSUMÉ

Resumen El objetivo fue determinar las estrategias y necesidades educativas de padres de bebés prematuros en un hospital de Cali, Colombia. El estudio fue cualitativo de sistematización de experiencias centrada en un proceso de intervención mediada. Los ejes de la sistematización fueron: las necesidades educativas y las estrategias de mejoramiento. La muestra estuvo conformada por 11 madres y padres quienes recibieron educación en el contexto de un programa de seguimiento, seleccionados a través de un muestreo opinático por criterios, entrevistados en profundidad. Se realizó análisis de contenido temático. Se encontró que las necesidades educativas se agrupan en los cuidados del bebé: conocimientos básicos, conductas y emociones, condición de salud y alimentación y cuidados del cuidador. Las estrategias se enfocaron en el uso y aprovechamiento de las tecnologías de la información, la escuela de padres y la integración del grupo familiar. (AU)


Abstract We aimed to identify educational strategies and needs of parents of premature babies hospital in Cali, Colombia. We conducted a qualitative study of systematization of experiences focused on a process of mediated intervention. The axes of the systematization were: parental educational needs and improvement strategies for the follow-up program. The sample consisted of 11 mothers and parents who received education during a follow-up program, selected through an opinion-based sampling criterion. We conducted in-depth interviews with the parents and then used thematic content analysis. We found parental educational needs grouped into baby care: basic knowledge, behaviors and emotions, health and nutritional condition, and caregiver care. Improvement strategies suggested for the program focused on the use of information technologies, the parents' school, and the integration of families (AU)


Resumo O objetivo foi determinar as estratégias e necessidades educativas dos pais de bebês prematuros em um hospital de Cali, Colômbia. O estudo foi qualitativo de sistematização de experiências centradas num processo de intervenção mediado. Os eixos de sistematização foram: necessidades educativas e estratégias de melhoria. A amostra foi composta por 11 pais e mães que receberam educação no contexto de um programa de acompanhamento, selecionados por amostragem de opinião por critérios, entrevistados em profundidade. Foi realizada análise de conteúdo temática. Constatou-se que as necessidades educativas se agrupam nos seguintes cuidados com o bebê: conhecimentos básicos, comportamentos e emoções, estado de saúde, alimentação e cuidados do cuidador. As estratégias centraram-se na utilização e exploração das tecnologias de informação, na escola para os pais e na integração do grupo familiar. (AU)

7.
Front Microbiol ; 13: 1002963, 2022.
Article de Anglais | MEDLINE | ID: mdl-36160188

RÉSUMÉ

The development of high-throughput sequencing (HTS) technologies and metagenomics protocols deeply impacted the discovery of viral diversity. Moreover, the characterization of novel viruses in the Neotropical primates (NP) is central for the comprehension of viral evolution dynamics in those hosts, due to their evolutionary proximity to Old World primates, including humans. In the present work, novel anelloviruses were detected and characterized through HTS protocols in the NP Callithrix penicillata, the common black-tufted marmoset. De novo assembly of generated sequences was carried out, and a total of 15 contigs were identified with complete Anelloviridae ORF1 gene, two of them including a flanking GC-rich region, confirming the presence of two whole novel genomes of ~3 kb. The identified viruses were monophyletic within the Epsilontorquevirus genus, a lineage harboring previously reported anelloviruses infecting hosts from the Cebidae family. The genetic divergence found in the new viruses characterized two novel species, named Epsilontorquevirus callithrichensis I and II. The phylogenetic pattern inferred for the Epsilontorquevirus genus was consistent with the topology of their host species tree, echoing a virus-host diversification model observed in other viral groups. This study expands the host span of Anelloviridae and provides insights into their diversification dynamics, highlighting the importance of sampling animal viral genomes to obtain a clearer depiction of their long-term evolutionary processes.

8.
J Surg Oncol ; 126(1): 139-143, 2022 Jul.
Article de Anglais | MEDLINE | ID: mdl-35689573

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Previous studies demonstrated an association between OX40+T cell expression with poor prognosis in gastric cancer (GC). The soluble form of OX40 (sOX40) could block the interactions between OX40 on the effector T cell, and it is a ligand (OX40L) in dendritic cells. However, the role of sOX40 as a pretreating biomarker and prognostic predictor remains unclear. This study aimed to evaluate the association of levels of sOX40 and sOX40L with disease progression in GC. METHODS: Between 2017 and 2018, a cross-sectional study was performed on 83 GC patients and 20 healthy controls. RESULTS: Among 83 GC patients (median of 63 years), 32.4% of patients with I/II stages, 42.3% III, and 25.3% in IV stages. Metastatic GC patients had significantly higher levels of soluble OX40 compared with stage III (p = 0.0003) and early stages I and II patients (p = 0.005). There was no significant differences in the sOX40 and sOX40L levels between Lauren's histological subtype (intestinal, diffuse, and mixed). CONCLUSIONS: This study showed that soluble OX40 levels have an essential role in GC progression. OX40 molecules may constitute a predictor for poor prognosis and a potential target for immunotherapy in GC.


Sujet(s)
Tumeurs de l'estomac , Marqueurs biologiques/métabolisme , Études transversales , Humains , Tumeurs de l'estomac/métabolisme , Lymphocytes T/métabolisme
9.
J Surg Oncol ; 126(1): 144-149, 2022 Jul.
Article de Anglais | MEDLINE | ID: mdl-35689579

RÉSUMÉ

BACKGROUND AND OBJECTIVES: T cells are central in antitumor immunity in gastric cancer (GC). The inducible costimulatory molecule (ICOS) is a T cell receptor that primarily transmits positive signals for T cell activation and is associated with poor prognosis in GC. In contrast, the costimulatory molecule programmed death 1 (PD-1) is an inhibitory receptor related to tumor immune escape. This study aimed to analyze soluble sites and sPD-1 levels in GC. METHODS: This study enrolled 83 GC patients and 20 healthy controls. RESULTS: The median survival time was 23.22 months in the GC patients. Low levels of sPD-1 and sICOS in GC patients compared to the control group (p = 0.003; p < 0.0001, respectively). High sPD-1 levels in stage IV patients compared to I/II and III stages groups (p = 0.008 and p = 0.0004, respectively). GC patients with stages I and II had higher levels of sICOS compared to III and IV stages (p = 0.0005 and p = 0.02, respectively). There were no significant differences in sPD-1 and sICOS levels between Lauren subtypes. CONCLUSION: These results suggest a predominance of inhibitory costimulatory signals in advanced stages of GC, facilitating tumor immune escape, as the opposite occurs in early stages, resulting in an effective antitumor T-cell-mediated immune response.


Sujet(s)
Tumeurs de l'estomac , Antigène CD274/métabolisme , Humains , Tumeurs de l'estomac/anatomopathologie
10.
J Surg Oncol ; 126(1): 125-131, 2022 Jul.
Article de Anglais | MEDLINE | ID: mdl-35689589

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Gastric cancer (GC) remains responsible for over one million new cases in 2020. Activated platelets express the CD40 ligand (CD40L) and CD62P in the cytoplasmic membrane, and interaction with the vascular endothelium can induce the production of tumor growth factors and metastases. We aimed to characterize the soluble levels of sCD40L and sCD62P in GC patients. METHODS: A cross-sectional study was performed on 83 GC patients and 20 healthy controls. RESULTS: High levels of sCD40L were obtained in GC patients compared to healthy controls (p = 0.003) and in the I/II compared with III and IV stages (p < 0.0001 and p = 0.007, respectively). Low levels of sCD62P in the GC patients compared to healthy controls (p = 0.009). High soluble levels of sCD62P in I/II compared with III and IV stages (p = 0.002 and p = 0.01, respectively). There are no significant differences in the levels of sCD40L and sCD62P were observed between intestinal, diffuse, and mixed types. CONCLUSIONS: We concluded that sCD40L and sCD62P molecules may be predictive biomarkers since the increase in plasma levels was associated with disease progression and metastasis in GC. In addition, the serum sCD40L and sCD62P can potentially be used as an indicator of response to anticancer therapy.


Sujet(s)
Tumeurs de l'estomac , Marqueurs biologiques/métabolisme , Plaquettes/métabolisme , Ligand de CD40 , Carcinogenèse , Transformation cellulaire néoplasique/métabolisme , Études transversales , Humains , Activation plaquettaire , Tumeurs de l'estomac/métabolisme
11.
Biochem Biophys Res Commun ; 606: 168-173, 2022 05 28.
Article de Anglais | MEDLINE | ID: mdl-35364325

RÉSUMÉ

The New World (NW) mammarenavirus Junín (JUNV) is the etiological agent of Argentine hemorrhagic fever, a human endemic disease of Argentina. Promyelocytic leukemia protein (PML) has been reported as a restriction factor for several viruses although the mechanism/s behind PML-mediated antiviral effect may be diverse and are a matter of debate. Previous studies have reported a nuclear to cytoplasm translocation of PML during the murine Old World mammarenavirus lymphocytic choriomeningitis virus (LCMV) infection. This translocation was found to be mediated by the viral Z protein. Here, we show that PML restricts JUNV infection in human A549 cells. However, in contrast to LCVM, JUNV infection enhances PML expression and PML is not translocated to the cytoplasm neither it colocalizes with JUNV Z protein. Our study demonstrates that a NW mammarenavirus as JUNV interacts differently with the antiviral protein PML than LCMV.


Sujet(s)
Fièvre hémorragique américaine , Virus Junin , Protéine de la leucémie promyélocytaire , Cellules A549 , Fièvre hémorragique américaine/métabolisme , Humains , Protéine de la leucémie promyélocytaire/génétique , Protéines virales , Réplication virale
12.
J Gen Physiol ; 154(4)2022 04 04.
Article de Anglais | MEDLINE | ID: mdl-35323838

RÉSUMÉ

As an opportunistic predator, the Burmese python (Python molurus bivittatus) consumes large and infrequent meals, fasting for up to a year. Upon consuming a large meal, the Burmese python exhibits extreme metabolic responses. To define the pathways that regulate these postprandial metabolic responses, we performed a comprehensive profile of plasma metabolites throughout the digestive process. Following ingestion of a meal equivalent to 25% of its body mass, plasma lipoproteins and metabolites, such as chylomicra and bile acids, reach levels observed only in mammalian models of extreme dyslipidemia. Here, we provide evidence for an adaptive response to postprandial nutrient overload by the python liver, a critical site of metabolic homeostasis. The python liver undergoes a substantial increase in mass through proliferative processes, exhibits hepatic steatosis, hyperlipidemia-induced insulin resistance indicated by PEPCK activation and pAKT deactivation, and de novo fatty acid synthesis via FASN activation. This postprandial state is completely reversible. We posit that Burmese pythons evade the permanent hepatic damage associated with these metabolic states in mammals using evolved protective measures to inactivate these pathways. These include a transient activation of hepatic nuclear receptors induced by fatty acids and bile acids, including PPAR and FXR, respectively. The stress-induced p38 MAPK pathway is also transiently activated during the early stages of digestion. Taken together, these data identify a reversible metabolic response to hyperlipidemia by the python liver, only achieved in mammals by pharmacologic intervention. The factors involved in these processes may be relevant to or leveraged for remediating human hepatic pathology.


Sujet(s)
Boidae , Adaptation physiologique , Animaux , Boidae/métabolisme , Humains , Foie , Mammifères , Nutriments , Période post-prandiale/physiologie
14.
Microbiol Spectr ; 10(1): e0167821, 2022 02 23.
Article de Anglais | MEDLINE | ID: mdl-35171030

RÉSUMÉ

Urinary tract infections (UTIs) are the second most frequent bacterial infections worldwide, with Escherichia coli being the main causative agent. The increase of antibiotic-resistance determinants among isolates from clinical samples, including UTIs, makes the development of novel therapeutic strategies a necessity. In this context, the use of bacteriophages as a therapeutic alternative has been proposed, due to their ability to efficiently kill bacteria. In this work, we isolated and characterized three novel bacteriophages, microbes laboratory phage 1 (MLP1), MLP2, and MLP3, belonging to the Chaseviridae, Myoviridae, and Podoviridae families, respectively. These phages efficiently infect and kill laboratory reference strains and multidrug-resistant clinical E. coli isolates from patients with diagnosed UTIs. Interestingly, these phages are also able to infect intestinal pathogenic Escherichia coli strains, such as enteroaggregative E. coli and diffusely adherent E. coli. Our data show that the MLP phages recognize different regions of the lipopolysaccharide (LPS) molecule, an important virulence factor in bacteria that is also highly variable among different E. coli strains. Altogether, our results suggest that these phages may represent an interesting alternative for the treatment of antibiotic-resistant E. coli. IMPORTANCE Urinary tract infections affect approximately 150 million people annually. The current antibiotic resistance crisis demands the development of novel therapeutic alternatives. Our results show that three novel phages, MLP1, MLP2, and MLP3 are able to infect both laboratory and multidrug-resistant clinical isolates of Escherichia coli. Since these phages (i) efficiently kill antibiotic-resistant clinical isolates of uropathogenic Escherichia coli (UPEC), (ii) recognize different portions of the LPS molecule, and (iii) are able to efficiently infect intestinal pathogenic Escherichia coli hosts, we believe that these novel phages are good candidates to be used as a therapeutic alternative to treat antibiotic-resistant E. coli strains generating urinary tract and/or intestinal infections.


Sujet(s)
Bactériophages/classification , Bactériophages/isolement et purification , Multirésistance bactérienne aux médicaments , Escherichia coli/virologie , Antibactériens/pharmacologie , Multirésistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Infections à Escherichia coli/microbiologie , Interactions hôte-microbes/physiologie , Spécificité d'hôte , Humains , Lipopolysaccharides , Phagothérapie , Podoviridae , Infections urinaires/microbiologie , Escherichia coli uropathogène/pathogénicité , Facteurs de virulence
16.
J Med Virol ; 94(3): 1206-1211, 2022 03.
Article de Anglais | MEDLINE | ID: mdl-34647634

RÉSUMÉ

The Lambda variants of interest (VOI) (C37/GR/452Q.V1/21G) was initially reported in Lima, Peru but has gained rapid dissemination through other Latin American countries. Nevertheless, the dissemination and molecular epidemiology of the Lambda VOI in Brazil is unknown apart from a single case report. In this respect, we characterized the circulation of the SARS-CoV-2 Lambda VOI (C37/GR/452Q.V1/21G) in Sao Paulo State, Brazil. From March to June 2021, we identified seven Lambda isolates in a set of approximately 8000 newly sequenced genomes of the Network for Pandemic Alert of Emerging SARS-CoV-2 variants from Sao Paulo State. Interestingly, in three of the positive patients, the Lambda VOI infection was probably related to a contact transmission. These individuals were fully vaccinated to COVID-19 and presented mild symptoms. The remaining positive for Lambda VOI individuals showed different levels of COVID-19 symptoms and one of them needed hospitalization (score 5, WHO). In our study, we present a low level of Lambda VOI circulation in the Sao Paulo State. This reinforces the essential role of molecular surveillance for the effective SARS-CoV-2 pandemic response, especially in regard to circulating variants.


Sujet(s)
COVID-19 , SARS-CoV-2 , Brésil/épidémiologie , COVID-19/épidémiologie , Humains , SARS-CoV-2/génétique , Organisation mondiale de la santé
17.
Clin Exp Rheumatol ; 39 Suppl 133(6): 93-99, 2021.
Article de Anglais | MEDLINE | ID: mdl-34796845

RÉSUMÉ

OBJECTIVES: In this observational, analytical, cross-sectional study we aimed to describe the impact of primary Sjögren's syndrome (pSS) on work productivity and activities of daily living (ADL) to assess the association between ADL impairment and clinical manifestations and to compare ADL impairment according to patients' socioeconomic condition. METHODS: Patients diagnosed with pSS attending 11 centres from Argentina were included. To evaluate work productivity and ADL impairment, a work productivity and activity impairment questionnaire (WPAI) was used. A multiple linear regression model was performed, considering deterioration on ADL due to health as a dependent variable, adjusted for potential confounders. RESULTS: 252 patients were included, 98.4% were women, with a mean age of 52.6 years (±14.8). The average percentage of time lost due to health was 15.7 hours (±30.1 95% CI: 9.6-21.9); the decrease in work productivity was 27.2 (±30.2 95% CI: 21.3-33.1), the total disability was 33.7 (±35.8 95% CI: 26.4-4) and ADL deterioration was 34.2 (±30.9. 95% CI: 30.4-38). In the multivariate analysis, xerostomia, arthritis and depression showed significant and independent association. The mean of ADL impairment was 38.2 (±30.7) in patients attending public centres versus 28 (± 30.6) in private centres, which was a statistically significant difference. CONCLUSIONS: We found a compromise in all WPAI domains. Arthritis, xerostomia and depression were associated significantly and independently with ADL impairment. Deterioration in ADL was greater in patients treated in public centres. Considering these aspects will allow a better understanding of patients who suffer from this disease.


Sujet(s)
Activités de la vie quotidienne , Syndrome de Gougerot-Sjögren , Argentine , Études transversales , Humains , Adulte d'âge moyen , Syndrome de Gougerot-Sjögren/diagnostic , Syndrome de Gougerot-Sjögren/épidémiologie
18.
Viruses ; 13(7)2021 06 26.
Article de Anglais | MEDLINE | ID: mdl-34206727

RÉSUMÉ

The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-CoV-2 variants raised concerns on the efficacy of these vaccines. Herein, we report two cases of breakthrough infections with the P1 variant in patients vaccinated with CoronaVac, which is one of the two vaccines authorized for emergency use in the Brazilian immunization program. Our observations suggest that the vaccine reduced the severity of the disease and highlight the potential risk of illness following vaccination and subsequent infection with the P1 variant as well as for continued efforts to prevent and diagnose infection in vaccinated persons.


Sujet(s)
Anticorps antiviraux/sang , Vaccins contre la COVID-19/immunologie , COVID-19/imagerie diagnostique , COVID-19/immunologie , SARS-CoV-2/immunologie , Vaccination/effets indésirables , Brésil , COVID-19/prévention et contrôle , Détection de l'acide nucléique du virus de la COVID-19 , Vaccins contre la COVID-19/administration et posologie , Essais cliniques comme sujet , Dexaméthasone/usage thérapeutique , Humains , Mâle , Adulte d'âge moyen , SARS-CoV-2/génétique , Indice de gravité de la maladie , Tomodensitométrie , Résultat thérapeutique , Vaccination/statistiques et données numériques , Traitements médicamenteux de la COVID-19
19.
Mult Scler Relat Disord ; 55: 103173, 2021 Oct.
Article de Anglais | MEDLINE | ID: mdl-34332462

RÉSUMÉ

Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic.


Sujet(s)
COVID-19 , Sclérose en plaques , Humains , Amérique latine/épidémiologie , Sclérose en plaques/traitement médicamenteux , Sclérose en plaques/épidémiologie , Pandémies , SARS-CoV-2
20.
Mol Pharm ; 18(7): 2540-2555, 2021 07 05.
Article de Anglais | MEDLINE | ID: mdl-34106726

RÉSUMÉ

Dendritic cells serve as the main immune cells that trigger the immune response. We developed a simple and cost-effective nanovaccine platform based on the α1',2-mannobiose derivative for dendritic cell targeting. In previous work, we have formulated the α1,2-mannobiose-based nanovaccine platform with plasmid DNA and tested it in cattle against BoHV-1 infection. There, we have shown that the dendritic cell targeting using this nanovaccine platform in vivo can boost the immunogenicity, resulting in a long-lasting immunity. In this work, we aim to characterize the α1',2-mannobiose derivative, which is key in the nanovaccine platform. This DC-targeting strategy takes advantage of the specific receptor known as DC-SIGN and exploits its capacity to bind α1,2-mannobiose that is present at terminal ends of oligosaccharides in certain viruses, bacteria, and other pathogens. The oxidative conjugation of α1',2-mannobiose to NH2-PEG2kDa-DSPE allowed us to preserve the chemical structure of the non-reducing mannose of the disaccharide and the OH groups and the stereochemistry of all carbons of the reducing mannose involved in the binding to DC-SIGN. Here, we show specific targeting to DC-SIGN of decorated micelles incubated with the Raji/DC-SIGN cell line and uptake of targeted liposomes that took place in human, bovine, mouse, and teleost fish DCs in vitro, by flow cytometry. Specific targeting was found in all cultures, demonstrating a species-non-specific avidity for this ligand, which opens up the possibility of using this nanoplatform to develop new vaccines for various species, including humans.


Sujet(s)
Cellules présentatrices d'antigène/immunologie , Molécules d'adhérence cellulaire/immunologie , Cellules dendritiques/immunologie , Lectines de type C/immunologie , Lymphomes/immunologie , Mannose/composition chimique , Récepteurs de surface cellulaire/immunologie , Vaccins/immunologie , Animaux , Bovins , Femelle , Poissons , Humains , Lymphomes/thérapie , Mâle , Souris , Souris de lignée BALB C , Spécificité d'espèce , Vaccins/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE